Central Bank of India has received final approval from the Competition Commission of India (CCI) to increase its shareholding in two Generali insurance entities. The approval covers the acquisition of an additional 1.09% equity in Generali Central Insurance Company Limited (GCICL) and 0.82% in Generali Central Life Insurance Company Limited (GCLICL). Upon completion, the Bank’s stake in both ventures will consolidate to 26%, up from the current 24.91% and 25.18%, respectively.
Regulatory Green Light for Shareholding Increase
In a significant update to its investment portfolio, Central Bank of India confirmed receiving necessary regulatory clearance for a proposed combination concerning its insurance joint ventures. The approval was formally communicated by the Competition Commission of India (CCI) on March 3, 2026.
Details of the Proposed Acquisition
This clearance pertains to the Bank’s plan to acquire additional equity in its two existing insurance partnerships:
- Acquisition of an additional 1.09% equity in Generali Central Insurance Company Limited (GCICL).
- Acquisition of an additional 0.82% equity in Generali Central Life Insurance Company Limited (GCLICL).
Impact on Final Stake
Following the successful completion of this proposed acquisition, the Bank’s shareholding in both the general and life insurance entities will reach a consolidated figure of 26%. This reflects an increase from the pre-approved levels, which stood at 24.91% for GCICL and 25.18% for GCLICL, solidifying the Bank’s commitment to these long-term partnerships.
Source: BSE
